title: Re: Michael T. Schweizer, Xian C. Zhou, Hao Wang, et al. The Influence of Prior Abiraterone Treatment on the Clinical Activity of Docetaxel in Men with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2014;66:646-52.
authors.affiliation: Oncology Department, Nottingham University Hospitals NHS Trust, Nottingham, UK. Electronic address: michael.o'cathail@nuh.nhs.uk.
authors.forename: Micheal
authors.initials: M
authors.lastname: O'Cathail
authors.affiliation: Oncology Department, Nottingham University Hospitals NHS Trust, Nottingham, UK.
authors.forename: Santhanam
authors.initials: S
authors.lastname: Sundar
mesh_terms: D000736:Androstenes / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary*; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary*; D008297:Male; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy* / Q000473:pathology*; D043823:Taxoids / Q000008:administration & dosage*
chemical_list: D000736:Androstenes; D043823:Taxoids